Health

Sotera Health Delivers Strong First-Quarter 2026 Results and Reaffirms 2026 Outlook

Q1 2026 net revenues increased 10.0%, or 6.5% on a constant currency basis, compared to Q1 2025Q1 2026 net income…

2 months ago

Invivyd Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

May 05, 2026 07:01 ET  | Source: Invivyd NEW HAVEN, Conn., May 05, 2026 (GLOBE NEWSWIRE) -- Invivyd, Inc. (Nasdaq:…

2 months ago

TimelyCare Acquires Alongside to Expand Continuous Student Support with Clinician-Powered AI Coaching

Fort Worth, TX, May 04, 2026 (GLOBE NEWSWIRE) -- May 4, 2026 — TimelyCare, education’s most trusted virtual care provider, today…

2 months ago

Flyte Increases Capacity and Launches Hiring Initiative as Spirit Airlines Shutdown Disrupts U.S. Air Travel

FORT MILL, SC, May 04, 2026 (GLOBE NEWSWIRE) -- — Flyte, the regional air mobility subsidiary of Catheter Precision, Inc.…

2 months ago

ApolloMD Surpasses $1.5 Billion in Patient Debt Relief Through Ongoing Partnership with Cascade365, Coordinated by Undue Medical Debt

ATLANTA, May 04, 2026 (GLOBE NEWSWIRE) -- ApolloMD has helped eliminate more than $1.5 billion in patient medical debt since…

2 months ago

Milken Institute Global Conference 2026 Set to Open Tomorrow in Beverly Hills with KFSH Participation

BEVERLY HILLS, Calif., May 02, 2026 (GLOBE NEWSWIRE) -- The Milken Institute Global Conference 2026 is set to open tomorrow…

2 months ago

Eupraxia Pharmaceuticals Appoints Dr. Jeymi Tambiah as Chief Medical Officer

May 01, 2026 17:05 ET  | Source: Eupraxia Pharmaceuticals Inc. VANCOUVER, British Columbia, May 01, 2026 (GLOBE NEWSWIRE) -- Eupraxia…

2 months ago

Celcuity’s Phase 3 VIKTORIA-1 Trial Achieves Primary Endpoint With Clinically Meaningful Improvement in Progression-Free Survival in PIK3CA Mutant Cohort

MINNEAPOLIS, May 01, 2026 (GLOBE NEWSWIRE) -- Celcuity Inc. (Nasdaq: CELC), a clinical-stage biotechnology company pursuing development of targeted therapies…

2 months ago

MemoPryl Gets Reviewed: Complete Formula Evaluation of Ingredient Claims and Side Effects Risk

Aurora, CO, May 02, 2026 (GLOBE NEWSWIRE) -- These statements have not been evaluated by the Food and Drug Administration.…

2 months ago

VisioCore Claims Evaluated: The 8-Second Amazonian Morning Flush For Crystal Clear Vision Support

Aurora, CO, May 02, 2026 (GLOBE NEWSWIRE) -- These statements have not been evaluated by the Food and Drug Administration.…

2 months ago